» Articles » PMID: 28938958

Pulmonary Hemodynamics in Heart Failure Patients with Reduced or Preserved Ejection Fraction and Pulmonary Hypertension: Similarities and Disparities

Overview
Journal Am Heart J
Date 2017 Sep 24
PMID 28938958
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The current understanding of pulmonary hypertension (PH) due to left ventricular diseases does not distinguish heart failure (HF) with reduced ejection fraction (HFrEF) from HF and preserved ejection fraction (HFpEF), in terms of pulmonary hemodynamics. The value of pulmonary vascular compliance (PCa) and diastolic pulmonary gradient (DPG) as predictors of survival in either HF syndrome is controversial. The aims of our study were to compare the pulmonary hemodynamics in the two HF phenotypes, given similar values of pulmonary artery wedge pressure (PAWP), and to evaluate the impact of PCa and DPG on survival.

Methods: We retrospectively reviewed the charts of 168 PH-HFrEF and 86 PH-HFpEF patients. The independent association of PCa and DPG with prognosis was assessed by means of a Cox proportional hazard model. All cause survival was analyzed over an average follow-up period of 50 months.

Results: PH-HFpEF patients had a significantly higher DPG than PH-HFrEF patients (6.1±7.1 vs 1.8±4.5 mmHg, adjusted P=.025). PCa was similar in PH-HFpEF and PH-HFrEF. PCa was a significant predictor of survival, according to previously described preset cutoffs (2.15 mL/mmHg in HFrEF and 1.1 mL/mmHg in HFpEF) and based on a continuous scale; whereas DPG had no impact on survival in both patients groups.

Conclusion: Our findings suggest that for similar levels of PAWP, pulmonary circulation may be stiffer in patients with HFpEF-PH than patients with HFrEF-PH, leading to higher DPGs. Nonetheless, PCa rather than DPG emerged as the stronger predictor of survival in both left-sided PH phenotypes.

Citing Articles

Prevalence of pulmonary hypertension and associated factors among rheumatic heart disease patients in Ethiopia.

Gedefaw A, Ayele Y, Wudie G, Tefera A, Yirdaw A, Demilew T BMC Cardiovasc Disord. 2025; 25(1):20.

PMID: 39810078 PMC: 11734543. DOI: 10.1186/s12872-025-04476-3.


Pulmonary hypertension associated with left heart disease.

Maron B, Bortman G, De Marco T, Huston J, Lang I, Rosenkranz S Eur Respir J. 2024; 64(4).

PMID: 39209478 PMC: 11525340. DOI: 10.1183/13993003.01344-2024.


Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.

Fauvel C, Damy T, Berthelot E, Bauer F, Eicher J, de Groote P Eur Heart J. 2024; 45(35):3274-3288.

PMID: 39056467 PMC: 11400736. DOI: 10.1093/eurheartj/ehae467.


Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction.

Aradhyula V, Vyas R, Dube P, Haller S, Gupta R, Maddipati K Am J Physiol Heart Circ Physiol. 2024; 326(6):H1498-H1514.

PMID: 38639739 PMC: 11380948. DOI: 10.1152/ajpheart.00068.2024.


A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.

Munks J, Yogeswaran A, Antoine T, Blumrich L, Dorfmuller P, Ghofrani H Int J Mol Sci. 2024; 25(5).

PMID: 38474074 PMC: 10932337. DOI: 10.3390/ijms25052827.